CTS-236: Biomembranes
Group created in January 1990. Its first line of research involved the study of the “Interaction of xenobiotics in rat liver and its repercussion on lipid metabolism”.
Current lines of research involve the study of synthetic lipid analogues as anti-tumour agents.